Pharmaceutical formulation
US7338667B2 · kind B2 · utility
3Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2003 |
| Grant date | Mar 4, 2008 |
| Priority date | — |
| Expiry date | Feb 22, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4468
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low solubility in water dispersed or dissolved in at least one erasable hydrophilic polymeric matrix.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.